Infarction D007238

Description

Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.   MeSH

Hierarchy View

Subtype Terms (5)

Brain Infarction
11 drugs (7 approved, 4 experimental)

Hepatic Infarction
 

Myocardial Infarction
296 drugs (174 approved, 122 experimental)

Pulmonary Infarction
1 approved drug


Phase 1 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (268)

Aalborg University

Aarhus University

Aarne Koskelo Foundation

Academy of Athens

Accumetrics, Inc.

Allegheny Health Network

Amylin

A.R. CARD Onlus Foundation

AstraZeneca

Athens Red Cross Hospital

Azienda Sanitaria Ospedaliera

Bayer

B. Braun

Beijing Bozhiyin T&S Co., Ltd.

Ben Gurion University

Boehringer Ingelheim

Boston Scientific Corporation

Bristol-Myers Squibb

Burnasyan Federal Medical Biophysical Center

Byrraju Foundation

Campus Bio-Medico University

Canadian Institutes of Health Research (CIHR)

Cancer Research Network

Capital Medical University

Catholic University of Sacred Heart, Rome

Cedars-Sinai Medical Center

Central Denmark Region

Central South University

Chang Gung University

Charles University

Chiesi

China Medical University

China Resources Zizhu Pharmaceutical Co., Ltd.

Chinese Academy of Medical Sciences

CHINESE ARMED POLICE FORCE GENRAL HOSPITAL

Chinese Center of Diseases Control and Prevention

Chonbuk National University

Chonnam National University

Chrono-Log Corporation

Chungnam National University

CLI Foundation

Compusense Oegstgeest

Cordis

Croatian Science Foundation

Dalian Medical University

Dammam Central Hospital

Danish Heart Foundation

Department of Veteran Affairs

Dong-A University

Edwards Lifesciences

Eisai

Eli Lilly

Erasmus University Rotterdam

Evangelismos Hospital

Federal University of Rio Grande do Sul

Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital

Fengtian Hospital

Finnish Foundation for Cardiovascular Research

Florida Atlantic University

Fondo de Investigacion Sanitaria

Free University of Amsterdam

Fudan University

Fundação de Amparo à Pesquisa do Estado de São Paulo

Fundacja Ośrodek Badań Medycznych

Fund for Clinical Cardiovascular Research at LRD

Gelderse Vallei Hospital

Gelre Hospitals

Genentech

General Electric

General Hospital of Chinese Armed Police Forces

Gennimatas Hospital, Athens

GlaxoSmithKline

Government of China

Government of Czech Republic

Government of Spain

Green Valley Group of China

Guangdong Provincial Hospital of Traditional Chinese Medicine

Guangzhou Medical University

Guangzhou Recomgen Biotech Co., Ltd.

Guangzhou University

Guidant Corporation

Gyeongsang University

Hamilton Health Sciences Corporation

Harvard University

Hebei University

Helena Laboratories Point of Care

Huazhong University of Science and Technology

Icahn School of Medicine at Mount Sinai

Imam Abdulrahman Bin Faisal University

Imperial College London

Inha University

Inje University

Inova Health System

Instituto Dante Pazzanese de Cardiologia

Instituto Mexicano del Seguro Social

Intermountain Health Care

Intermountain Heart Institute

Isala Clinics, Zwolle, The Netherlands

Istanbul University

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Clinico Sant'Ambrogio

ISU ABXIS

Japan Heart Foundation

Jiao Tong University

Jinan University

Karolinska Institute

Katholieke Universiteit Leuven

King Fahad Armed Forces Hospital

Kobe University

Korean Society of Interventional Cardiology

Korea University

Krakowskie Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii Carint Scanmed Sp. z o.o

Kumamoto University

Kyoto Prefectural University of Medicine

Kyoto University

Kyung Hee University

Kyungpook University

Lantheus Medical Imaging

Laval University

Leiden University

LifeBridge Health

Life Sciences Research Partners

Lund University

Lytics

Maastricht University

McMaster University

Meander Medical Center

Medical Center Leeuwarden

Medical Center of South Arkansas

Medical University of Warsaw

Medisch Spectrum Twente

Medtronic

Melbourne Health

Merck

Mid America Heart Institute

Misericordia and Dolce Hospital

Mitsubishi Tanabe

Mochida Pharmaceutical Company, Ltd.

Myung In Pharmaceutical Company

Nanjing Medical University

National Health and Medical Research Council, Australia

National Heart, Lung, and Blood Institute (NHLBI)

National Institute of Neurological Disorders and Stroke (NINDS)

National Natural Science Foundation of China

National University of Singapore

New York University

Nicolaus Copernicus University

Noordwest Ziekenhuisgroep

Norra Alvsborgs Lans Hospital, Trollhattan

Norwegian University of Science and Technology

Novartis

Novo Nordisk

Orebro University

Orion Corporation

Osaka Acute Coronary Insufficiency Study Group

Osaka General Medical Center

Osaka University

Ospedale della Misericordia - Grosseto

Ospedale Maggiore, Novara

Ospedale Misericordia e Dolce, Prato

Otsuka

Peking University

Penza State University

People's Liberation Army of China

Pfizer

Platelet and Thrombosis Research L.L.C

Pusan National University

R&D Cardiologie

Regeneron

Region of Southern Denmark

Region Örebro County

Region Skane

Region Zealand

Rijnstate Hospital

Rush University

Saint Luke's Health System

Sanofi

Sanofi-Aventis

Schulz Foundation

Seoul National University

Shanghai Xuhui District Central Hospital

Sheffield Hallam University

SHF Svendborg

Silesian University of Medicine

Soochow University

SOS Attaque Cérébrale

Southeast University

Spanish Society of Cardiology

St. Antonius Hospital, Nieuwegein

Stockholm South General Hospital

Sungkyunkwan University

Swedish Heart Lung Foundation

Taichung Veterans General Hospital

Teaching Hospital Královské Vinohrady (FNKV)

Technical University of Munich

Technion University

Techpool Bio-Pharma Co., Ltd.

Tel Aviv University

Temple University

The Baruch Padeh Medical Center, Poriya

The Capital Region of Denmark

The Future Forum, UK

The North Denmark Region

The Royal Wolverhampton NHS Trust

The Swedish Research Council

The TIMI Study Group

The University of Hong Kong

Tsinghua University

Universidad Carlos III Madrid

Universidad Complutense de Madrid

University Hospital of North Norway

University of Alberta

University of Amsterdam

University of Athens

University of Barcelona

University of Bern

University of Bologna

University of Bordeaux

University of Brasilia

University of British Columbia

University of Campania Luigi Vanvitelli

University of Campinas

University of Copenhagen

University of Eastern Piedmont

University of Florence

University of Florida

University of Glasgow

University of Gothenburg

University of Helsinki

University of Lille

University of Liverpool

University of Ljubljana

University of Lubeck

University of Lyon

University of Maryland

University of Milan

University of Modena and Reggio Emilia

University of New South Wales

University of Oslo

University of Ostrava

University of Ottawa

University of Oxford

University of Paris

University of Patras

University of Pennsylvania

University of Pisa

University of Roma La Sapienza

University of Sao Paulo

University of Siena

University of Southern Denmark

University of Stavanger

University of Texas at Houston

University of Toronto

University of Ulsan

University of Vienna

University of Wisconsin

University of Zagreb

Uppsala University

Utrecht University

Varberg Hospital, Sweden

Virginia Commonwealth University

Western Norway Regional Health Authority

Wilhelm Sander Foundation

Worldwide Clinical Trials

Yeshiva University

Yonsei University

Zhejiang University

Zuyderland Medisch Centrum

Organization Involved with Phase 3 Indications (208)

Abbott

Action Research Group

Airlangga University

Amgen

ARTTIC International Management Services

ARYx Therapeutics

AtheroGenics

Axio Research Corporation

Badalona Hospital Germans Trias i Pujol

Baqiyatallah Medical Sciences University

Basildon and Thurrock University Hospitals NHS Foundation Trust

Baylor University

Bharat Biotech International Limited

Binawaluya Cardiac Hospital

Bioheart, Inc.

Boston Health and Hospitals Department

Brazilian Clinical Research Institute

British Heart Foundation

Canadian Heart Research Centre

Canadian VIGOUR Centre

CardioVascular Research Foundation, Korea

Cardiovascular Research Foundation, New York

Cayetano Heredia University

Centers for Disease Control and Prevention (CDC)

Centocor

Central Army Hospital RSPAD Gatot Soebroto

Chiangmai University

CHIMES Society

Chinese People's Armed Police Forces

CHU Henri Mondor

Clinical Centre of Serbia

Clinical Hospital #15 Clinical Hospital #15 named after O.M.Filatov, Moscow, Russia

Cogentus Pharmaceuticals

Columbia University

Cornell University

Daiichi Sankyo

Dexa Medica Group

Diponegoro University

Duke University

Emory University

Eurofarma Laboratorios S.A.

FCB-Pharmicell Co Ltd.

Ferrer Internacional S.A.

Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway

French Cardiology Society

Fundacion Investigacion Interhospitalaria Cardiovascular

Georgetown University

George Washington University

Government of Mexico

Government of Norway

Government of Poland

Government of Singapore

Greater Baltimore Medical Center

Hamad Medical Corporation

Health Care Centers of Illinois

Heart and Stroke Foundation of Canada

Heart Care Foundation

Hebrew University

HEINZ NIXDORF-FOUNDATION

Hellenic Cardiovascular Research Society

Henry Ford Health System

Hospital Alessandro Manzoni Lecco

Hospital do Coracao

Hospital e Maternidade Celso Pierro

Hospital General Universitario Gregorio Marañon

Hospital Universitario Virgen Macarena

Humboldt University

Indonesia's Neurologists Organization (Perdossi)

Institute of Cardiology, Tomsk, Russia

Institut National de la Santé Et de la Recherche Médicale, France

Instituto de Ciencias del Corazon

Investigación Independiente S.A.

Isfahan University

Iuliu Hatieganu University of Medicine and Pharmacy

Japan Cardiovascular Research Foundation

John Paul II Hospital, Krakow

Johnson and Johnson

J. W. Goethe University

JW Pharmaceutical

Kennedy-Leigh charitable trust

Kepler University

Kosuyolu Heart Hospital

Kyowa Hakko Kogyo

Landeskrankenhaus Feldkirch

Lankenau Hospital

Linkoping University

Ludwig Maximilians University

Mario Negri Institute

Maryland Medical Research Institute

Max Planck Institute

Mayo Clinic

McGill University

Medical Research Council

Medical University of Graz

Medicure

Mt. Sinai Medical Center, Miami

National Cancer Institute (NCI)

National Center for Complementary and Integrative Health (NCCIH)

National Cerebral and Cardiovascular Center

National Institutes of Health (NIH)

Neurobiological Technologies

New England Research Institutes

New York Medical College

North Sichuan Medical University

Organization Involved with Phase 2 Indications (146)

Organization Involved with Other Experimental Indications (67)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.